Literature DB >> 5359530

[Relation between galactose and the crystalline lens].

J Nordmann.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5359530     DOI: 10.1007/bf00943995

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


× No keyword cloud information.
  26 in total

1.  FACTORS AFFECTING THE FORMATION OF SUGAR ALCOHOLS IN OCULAR LENS.

Authors:  J H KINOSHITA; S FUTTERMAN; K SATOH; L O MEROLA
Journal:  Biochim Biophys Acta       Date:  1963-08-13

2.  HYDRATION OF THE LENS DURING THE DEVELOPMENT OF GALACTOSE CATARACT.

Authors:  J H KINOSHITA; L O MEROLA
Journal:  Invest Ophthalmol       Date:  1964-12

3.  OSMOTIC EFFECTS ON THE AMINO ACID-CONCENTRATING MECHANISM IN THE RABBIT LENS.

Authors:  J H KINOSHITA; L O MEROLA; S HAYMAN
Journal:  J Biol Chem       Date:  1965-01       Impact factor: 5.157

4.  Osmotic changes in experimental galactose cataracts.

Authors:  J H KINOSHITA; L O MEROLA; E DIKMAK
Journal:  Exp Eye Res       Date:  1962-06       Impact factor: 3.467

5.  [Galactosemic cataract].

Authors:  L E FERREIRA
Journal:  Rev Bras Oftalmol       Date:  1961-12

6.  Defect in uptake of galactose-1-phosphate into liver nucleotides in congenital galactosemia.

Authors:  E P ANDERSON; K J ISSELBACHER; H M KALCKAR
Journal:  Science       Date:  1957-01-18       Impact factor: 47.728

7.  Cataracts Produced in Albino Rats on a Ration Containing a High Proportion of Lactose or Galactose.

Authors:  A M Yudkin; C H Arnold
Journal:  Trans Am Ophthalmol Soc       Date:  1935

8.  Galactosaemia.

Authors:  P T BRAY; R J ISAAC; A G WATKINS
Journal:  Arch Dis Child       Date:  1952-08       Impact factor: 3.791

9.  Another biochemical variant of galactosemia.

Authors:  S Kelly; C Dzierwa; D Baswell
Journal:  Exp Mol Pathol       Date:  1968-08       Impact factor: 3.362

10.  Deficiency of erythrocyte galactokinase in a patient with galactose diabetes.

Authors:  R Gitzelmann
Journal:  Lancet       Date:  1965-10-02       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.